In Summary :
"I feel that there is more for the market to discover in the IXC story, then the better understood PAR. IXC lacks the attention of the blockbuster OA market, however, picks up the benefits of the Orphan Drug market for IIH, and it is possible that any potential acquirers (in a company sale scenario) see other indications outside IIH as attractive and substantial."
In Summary : "I feel that there is more for the market to...
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.012M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 28219 | 8.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.6¢ | 2202 | 1 |
View Market Depth
| Last trade - 16.12pm 03/05/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable